Nasal Vaccine for COVID19

The world’s first nasal vaccine for COVID19 – based on technology licensed from Washington University – was approved Tuesday, Sept. 6 in India for emergency use. Since the vaccine is delivered via the nose, right where the virus enters the body, it has the potential to block infection and break the cycle of transmission, as well as prevent lung damage.

Comments are closed.